TickerFactsScreenerDevelopers

AGIOS PHARMACEUTICALS, INC. (AGIO) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $77.88M2011: $117.66M2012: $91.30M2013: $71.56M2014: $14.03M2015: $71.76M2016: $160.75M2017: $102.72M2018: $70.50M2019: $80.93M2020: $127.44M2021: $203.13M2022: $139.26M2023: $88.20M2024: $76.25M2025: $89.13M$89.13M
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$89.13M+16.9%
2024$76.25M-13.6%
2023$88.20M-36.7%
2022$139.26M-31.4%
2021$203.13M+59.4%
2020$127.44M+57.5%
2019$80.93M+14.8%
2018$70.50M-31.4%
2017$102.72M-36.1%
2016$160.75M+124.0%
2015$71.76M+411.5%
2014$14.03M-80.4%
2013$71.56M-21.6%
2012$91.30M-22.4%
2011$117.66M+51.1%
2010$77.88M—